Your session is about to expire
← Back to Search
Active study product for Concussion
Study Summary
This trial will investigate whether magnesium and riboflavin supplements can help reduce headache pain and duration in individuals with a concussion. Participants will be randomly assigned to take either the active supplements or placebo capsules once
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial include individuals who are above the age of 65?
"Individuals aged between 18 and 40 are eligible to participate in this trial."
Which individuals are eligible to participate in this research study?
"Individuals aged between 18 and 40 with a diagnosis of concussion are eligible to participate in this trial, which has spots available for approximately 108 participants."
Is this medical study currently accepting participants for enrollment?
"The search for suitable candidates is ongoing as detailed on clinicaltrials.gov. The study's original posting was on February 10th, 2020 and its latest update was made on February 6th, 2024."
What is the upper limit for participant enrollment in this research investigation?
"Affirmative. Data available on clinicaltrials.gov indicates that this investigation is actively seeking candidates. The trial was originally posted on February 10th, 2020 and last revised on February 6th, 2024. There are plans to enroll a total of 108 participants at a single site."
Has the investigational drug in this research study received approval from the FDA?
"The safety assessment by our team at Power rates the investigational product in this Phase 2 trial as a level 2. This grade signifies existing data on safety but not yet on efficacy."
Share this study with friends
Copy Link
Messenger